OvaScience (OVAS) Misses Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Leerink Partners Remains Sidelined on OvaScience (OVAS) Following 1Q
May 6, 2016 8:45 AM EDTLeerink Partners reiterated a Market Perform rating on OvaScience (NASDAQ: OVAS), and raised the price target to $7.00 (from $6.00), following the company's 1Q earnings report. OVAS reported EPS of ($0.80) which was below Leerink Partners' estimate of ($0.75). The weakness in EPS was due to higher than expected COGS and R&D... More
